Glioblastoma initiating cells, also called cancer stem cells (CSCs), are characterized as a CD133+ cell population within a tumor that possess the abilities to self-renew, generate neurospheres in vitro and reproduce the original tumor when administered in vivo to immunocompromised animals [3, 4, 5, 6, 7]. Here, PROM1 is linked to glioblastoma.